132 related articles for article (PubMed ID: 22659116)
1. Inhibition of ectonucleotidase with ARL67156 prevents the development of calcific aortic valve disease in warfarin-treated rats.
Côté N; El Husseini D; Pépin A; Bouvet C; Gilbert LA; Audet A; Fournier D; Pibarot P; Moreau P; Mathieu P
Eur J Pharmacol; 2012 Aug; 689(1-3):139-46. PubMed ID: 22659116
[TBL] [Abstract][Full Text] [Related]
2. ATP acts as a survival signal and prevents the mineralization of aortic valve.
Côté N; El Husseini D; Pépin A; Guauque-Olarte S; Ducharme V; Bouchard-Cannon P; Audet A; Fournier D; Gaudreault N; Derbali H; McKee MD; Simard C; Després JP; Pibarot P; Bossé Y; Mathieu P
J Mol Cell Cardiol; 2012 May; 52(5):1191-202. PubMed ID: 22366713
[TBL] [Abstract][Full Text] [Related]
3. Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.
Mahmut A; Boulanger MC; Bouchareb R; Hadji F; Mathieu P
Cardiovasc Res; 2015 Apr; 106(1):109-20. PubMed ID: 25644539
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation.
Kutryb-Zajac B; Jablonska P; Serocki M; Bulinska A; Mierzejewska P; Friebe D; Alter C; Jasztal A; Lango R; Rogowski J; Bartoszewski R; Slominska EM; Chlopicki S; Schrader J; Yacoub MH; Smolenski RT
Clin Res Cardiol; 2020 Feb; 109(2):137-160. PubMed ID: 31144065
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
6. P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease.
El Husseini D; Boulanger MC; Mahmut A; Bouchareb R; Laflamme MH; Fournier D; Pibarot P; Bossé Y; Mathieu P
J Mol Cell Cardiol; 2014 Jul; 72():146-56. PubMed ID: 24631773
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis.
Yamamoto K; Yamamoto H; Yoshida K; Kisanuki A; Hirano Y; Ohte N; Akasaka T; Takeuchi M; Nakatani S; Ohtani T; Sozu T; Masuyama T
Hypertens Res; 2010 Mar; 33(3):269-74. PubMed ID: 20057483
[TBL] [Abstract][Full Text] [Related]
8. Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE-/- mice.
Rattazzi M; Faggin E; Bertacco E; Nardin C; Pagliani L; Plebani M; Cinetto F; Guidolin D; Puato M; Pauletto P
Cardiovasc Ther; 2018 Aug; 36(4):e12438. PubMed ID: 29847020
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
Mahmut A; Boulanger MC; El Husseini D; Fournier D; Bouchareb R; Després JP; Pibarot P; Bossé Y; Mathieu P
J Am Coll Cardiol; 2014 Feb; 63(5):460-9. PubMed ID: 24161325
[TBL] [Abstract][Full Text] [Related]
10. Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3-D microenvironment.
Weber A; Barth M; Selig JI; Raschke S; Dakaras K; Hof A; Hesse J; Schrader J; Lichtenberg A; Akhyari P
FASEB J; 2018 Aug; 32(8):4356-4369. PubMed ID: 29558203
[TBL] [Abstract][Full Text] [Related]
11. ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson-Gilford progeria syndrome.
Villa-Bellosta R
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23698-23704. PubMed ID: 31690656
[TBL] [Abstract][Full Text] [Related]
12. A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin.
Osman L; Chester AH; Amrani M; Yacoub MH; Smolenski RT
Circulation; 2006 Jul; 114(1 Suppl):I566-72. PubMed ID: 16820639
[TBL] [Abstract][Full Text] [Related]
13. Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: implications for aortic valve calcification.
Rattazzi M; Bertacco E; Iop L; D'Andrea S; Puato M; Buso G; Causin V; Gerosa G; Faggin E; Pauletto P
Atherosclerosis; 2014 Dec; 237(2):568-76. PubMed ID: 25463090
[TBL] [Abstract][Full Text] [Related]
14. Mechanical strain induces the production of spheroid mineralized microparticles in the aortic valve through a RhoA/ROCK-dependent mechanism.
Bouchareb R; Boulanger MC; Fournier D; Pibarot P; Messaddeq Y; Mathieu P
J Mol Cell Cardiol; 2014 Feb; 67():49-59. PubMed ID: 24368096
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway.
Yu Z; Seya K; Daitoku K; Motomura S; Fukuda I; Furukawa K
J Pharmacol Exp Ther; 2011 Apr; 337(1):16-23. PubMed ID: 21205918
[TBL] [Abstract][Full Text] [Related]
16. Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis.
Bozbas H; Yildirir A; Demir O; Cakmak A; Karacaglar E; Yilmaz M; Eroglu S; Pirat B; Ozin B; Muderrisoglu H
J Heart Valve Dis; 2008 Jul; 17(4):371-5. PubMed ID: 18751465
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of calcific aortic valve disease: towards new pharmacological therapies.
Mathieu P; Boulanger MC; Bouchareb R
Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):851-62. PubMed ID: 24857537
[TBL] [Abstract][Full Text] [Related]
18. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiologic mechanisms of calcific aortic stenosis.
Alexopoulos A; Kaoukis A; Papadaki H; Pyrgakis V
Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):71-80. PubMed ID: 22361851
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor Egr-1 in calcific aortic valve disease.
Ghazvini-Boroujerdi M; Clark J; Narula N; Palmatory E; Connolly JM; DeFelice S; Xu J; Jian B; Hazelwood S; Levy RJ
J Heart Valve Dis; 2004 Nov; 13(6):894-903. PubMed ID: 15597579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
